USC/Norris Comprehensive Cancer Center — Los Angeles, California

Public research footprint of USC/Norris Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,215

Registered studies

386

Active

177

Recruiting now

536

Completed

259

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Urothelial Carcinoma · Unresectable Malignant Solid Neoplasm · Stage IV Bladder Cancer AJCC v8 · Metastatic Bladder Large Cell Neuroendocrine Carcinoma

Recently updated registry entries

NCT05687110 — Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With… (Recruiting)
NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)
NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at USC/Norris Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.